Effect of antiangiogenic therapy on slowly growing, poorly vascularized tumors in mice

Journal of the National Cancer Institute

Volumn 93, Issue 5, 2001, Pages 382-387

  Beecken, Wolf Dietrich C ^a   Fernandez, Antonio ^a   Joussen, Antonia M ^a   Achilles, Eike Gert ^a   Flynn, Evelyn ^a   Lo, Kin Ming ^b   Gillies, Stephen D ^b   Javaherian, Kashi ^a   Folkman, Judah ^a   Shing, Yuen ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b Lexigen Pharmaceuticals Corp   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; ANGIOSTATIN; FUMAGILLOL CHLOROACETYLCARBAMATE; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G; SODIUM CHLORIDE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLADDER CARCINOMA; CANCER CHEMOTHERAPY; CANCER TRANSPLANTATION; CAPILLARY DENSITY; CARCINOMA CELL; CELL PROLIFERATION; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; STATISTICAL ANALYSIS; TUMOR GROWTH; TUMOR VASCULARIZATION; TUMOR VOLUME;

EID: 0035819906     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/93.5.382     Document Type: Article

References (28)

1. What is the evidence that tumors are angiogenesis dependent?
2. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
3. Tumor angiogenesis and metastasis - Correlation in invasive breast carcinoma
4. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma
5. Tumor angiogenesis: Therapeutic implications
6. Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis
7. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth
8. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma
9. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
10. Maspin is an angiogenesis inhibitor
11. Inhibition of angiogenesis by interleukin-12 is mediated by the interferon-inducible protein 10
12. Thalidomide is an inhibitor of angiogenesis
13. Angiostatin induces and sustains dormancy of human primary tumors in mice
14. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice
15. Principles of chemotherapy
16. Angiogenesis research is on fast forward
17. Angiogenesis inhibitor TNP-470 suppresses the progression of experimentally-induced hepatocellular carcinoma in rats
18. A human tissue culture cell line from a transitional cell tumour of the urinary bladder: Growth, chromosome pattern and ultrastructure
19. Establishment and characterization of four human bladder tumor cell lines and sublines with different degrees of malignancy
20. TNP-470 (a fungus-derived inhibitor of angiogenesis) reduces proliferation of cultured fibroblasts isolated from primary pterygia: A possible drug therapy for pterygia
21. The fumagillin analogue TNP-470 inhibits DNA synthesis of vascular smooth muscle cells stimulated by platelet-derived growth factor and insulin-like growth factor-I. Possible involvement of cyclin-dependent kinase 2
22. TNP-470 inhibits growth and the production of vascular endothelial growth factor of uterine carcinosarcoma cells in vitro
23. High level expression and secretion of Fc-X fusion proteins in mammalian cells
24. CD31 immunoreactivity in carcinomas and mesotheliomas
25. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: An index of cell proliferation with evidence of deregulated expression in some neoplasms
26. Quantification of angiogenesis in solid human tumours: An international consensus on the methodology and criteria of evaluation
27. Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression
28. Tumor angiogenesis